In this CRA Podcast, Vice Presidents Tim Wilsdon and Cécile Matthews discuss the challenges facing companies in the rare disease space, focusing on the market’s evolution in the COVID-19 pandemic from policy and market access perspectives.
Listen and follow CRA on Spotify